{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:57:21Z","timestamp":1786978641080,"version":"build-2736575974"},"publisher-location":"Berlin, Heidelberg","reference-count":263,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_330","type":"book-chapter","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:09:16Z","timestamp":1759838956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["LMP2A\u2014The Other EBV Oncogene"],"prefix":"10.1007","author":[{"given":"Mariah","family":"Riel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"9","key":"330_CR1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006639","volume":"13","author":"B Abere","year":"2017","unstructured":"Abere B et al (2017) The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. PLoS Pathog 13(9):e1006639","journal-title":"PLoS Pathog"},{"key":"330_CR2","doi-asserted-by":"crossref","first-page":"1385233","DOI":"10.3389\/fnins.2024.1385233","volume":"18","author":"S Agostini","year":"2024","unstructured":"Agostini S et al (2024) EBV and multiple sclerosis: expression of LMP2A in MS patients. Front Neurosci 18:1385233","journal-title":"Front Neurosci"},{"issue":"3","key":"330_CR3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/JVI.79.3.1789-1802.2005","volume":"79","author":"MD Allen","year":"2005","unstructured":"Allen MD, Young LS, Dawson CW (2005) The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J Virol 79(3):1789\u20131802","journal-title":"J Virol"},{"issue":"Pt 7","key":"330_CR4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1099\/vir.0.2008\/001461-0","volume":"89","author":"LJ Anderson","year":"2008","unstructured":"Anderson LJ, Longnecker R (2008a) EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK\/MAPK pathway. J Gen Virol 89(Pt 7):1563\u20131568","journal-title":"J Gen Virol"},{"issue":"2","key":"330_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virol.2007.10.009","volume":"371","author":"LJ Anderson","year":"2008","unstructured":"Anderson LJ, Longnecker R (2008b) An auto-regulatory loop for EBV LMP2A involves activation of notch. Virology 371(2):257\u2013266","journal-title":"Virology"},{"issue":"1","key":"330_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood-2008-06-160937","volume":"113","author":"LJ Anderson","year":"2009","unstructured":"Anderson LJ, Longnecker R (2009) Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo. Blood 113(1):108\u2013116","journal-title":"Blood"},{"issue":"22","key":"330_CR7","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1073\/pnas.200366597","volume":"97","author":"GJ Babcock","year":"2000","unstructured":"Babcock GJ, Thorley-Lawson DA (2000) Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci USA 97(22):12250\u201312255","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"330_CR8","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1002\/j.1460-2075.1993.tb06205.x","volume":"12","author":"P Beaufils","year":"1993","unstructured":"Beaufils P et al (1993) The (YXXL\/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J 12(13):5105\u20135112","journal-title":"EMBO J"},{"issue":"Pt 10","key":"330_CR9","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1099\/vir.0.81906-0","volume":"87","author":"AI Bell","year":"2006","unstructured":"Bell AI et al (2006) Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87(Pt 10):2885\u20132890","journal-title":"J Gen Virol"},{"issue":"3","key":"330_CR10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<371::AID-IJC10>3.0.CO;2-D","volume":"81","author":"C Berger","year":"1999","unstructured":"Berger C et al (1999) Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations. Int J Cancer 81(3):371\u2013375","journal-title":"Int J Cancer"},{"issue":"42","key":"330_CR11","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.0907994106","volume":"106","author":"KT Bieging","year":"2009","unstructured":"Bieging KT, Amick AC, Longnecker R (2009) Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis. Proc Natl Acad Sci USA 106(42):17945\u201317950","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"330_CR12","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1182\/blood-2011-02-338434","volume":"118","author":"KT Bieging","year":"2011","unstructured":"Bieging KT et al (2011) A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma. Blood 118(26):6849\u20136859","journal-title":"Blood"},{"issue":"6578","key":"330_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K et al (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375(6578):296\u2013301","journal-title":"Science"},{"issue":"Pt 11","key":"330_CR14","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1099\/0022-1317-77-11-2807","volume":"77","author":"M Brielmeier","year":"1996","unstructured":"Brielmeier M et al (1996) The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. J Gen Virol 77(Pt 11):2807\u20132818","journal-title":"J Gen Virol"},{"issue":"Pt 5","key":"330_CR15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1099\/vir.0.81598-0","volume":"87","author":"MM Brinkmann","year":"2006","unstructured":"Brinkmann MM, Schulz TF (2006) Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J Gen Virol 87(Pt 5):1047\u20131074","journal-title":"J Gen Virol"},{"issue":"5","key":"330_CR16","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/jvi.66.5.2689-2697.1992","volume":"66","author":"L Brooks","year":"1992","unstructured":"Brooks L et al (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66(5):2689\u20132697","journal-title":"J Virol"},{"issue":"5","key":"330_CR17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00428-006-0294-2","volume":"449","author":"M Buettner","year":"2006","unstructured":"Buettner M, Heussinger N, Niedobitek G (2006) Expression of Epstein-Barr virus (EBV)-encoded latent membrane proteins and STAT3 activation in nasopharyngeal carcinoma. Virchows Arch 449(5):513\u2013519","journal-title":"Virchows Arch"},{"issue":"11","key":"330_CR18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/onc.2008.492","volume":"28","author":"R Bultema","year":"2009","unstructured":"Bultema R, Longnecker R, Swanson-Mungerson M (2009) Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis. Oncogene 28(11):1471\u20131476","journal-title":"Oncogene"},{"issue":"3","key":"330_CR19","first-page":"377","volume":"3","author":"AP Burke","year":"1990","unstructured":"Burke AP et al (1990) Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 3(3):377\u2013380","journal-title":"Mod Pathol"},{"issue":"5","key":"330_CR20","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/jvi.66.5.3257-3262.1992","volume":"66","author":"P Busson","year":"1992","unstructured":"Busson P et al (1992) Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 66(5):3257\u20133262","journal-title":"J Virol"},{"issue":"Pt 1","key":"330_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/0022-1317-76-1-139","volume":"76","author":"P Busson","year":"1995","unstructured":"Busson P et al (1995) Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J Gen Virol 76(Pt 1):139\u2013145","journal-title":"J Gen Virol"},{"issue":"3","key":"330_CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell RG et al (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9(3):405\u2013411","journal-title":"Immunity"},{"issue":"3","key":"330_CR23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/JVI.74.3.1101-1113.2000","volume":"74","author":"RG Caldwell","year":"2000","unstructured":"Caldwell RG, Brown RC, Longnecker R (2000) Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J Virol 74(3):1101\u20131113","journal-title":"J Virol"},{"issue":"3","key":"330_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ni1036","volume":"5","author":"S Casola","year":"2004","unstructured":"Casola S et al (2004) B cell receptor signal strength determines B cell fate. Nat Immunol 5(3):317\u2013327","journal-title":"Nat Immunol"},{"issue":"4","key":"330_CR25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1535-7163.MCT-10-0833","volume":"10","author":"O Cen","year":"2011","unstructured":"Cen O, Longnecker R (2011) Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma. Mol Cancer Ther 10(4):679\u2013686","journal-title":"Mol Cancer Ther"},{"key":"330_CR26","doi-asserted-by":"crossref","unstructured":"Cen O et al (2018) Spleen tyrosine kinase inhibitor TAK-659 prevents splenomegaly and tumor development in a murine model of Epstein-Barr virus-associated lymphoma. mSphere 3(4)","DOI":"10.1128\/mSphereDirect.00378-18"},{"issue":"4","key":"330_CR27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood.2024023847","volume":"144","author":"S Chaganti","year":"2024","unstructured":"Chaganti S et al (2024) Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial. Blood 144(4):392\u2013401","journal-title":"Blood"},{"issue":"3","key":"330_CR28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/2767-9764.CRC-23-0341","volume":"4","author":"AWY Chai","year":"2024","unstructured":"Chai AWY et al (2024) Establishment and characterization of an Epstein-Barr virus-positive cell line from a non-keratinizing differentiated primary nasopharyngeal carcinoma. Cancer Res Commun 4(3):645\u2013659","journal-title":"Cancer Res Commun"},{"issue":"9","key":"330_CR29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ijc.23374","volume":"122","author":"SY Chan","year":"2008","unstructured":"Chan SY et al (2008) Authentication of nasopharyngeal carcinoma tumor lines. Int J Cancer 122(9):2169\u20132171","journal-title":"Int J Cancer"},{"key":"330_CR30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/srep00353","volume":"2","author":"RA Chang","year":"2012","unstructured":"Chang RA, Miller SD, Longnecker R (2012) Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Sci Rep 2:353","journal-title":"Sci Rep"},{"issue":"Pt 1","key":"330_CR31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1099\/0022-1317-76-1-131","volume":"76","author":"F Chen","year":"1995","unstructured":"Chen F et al (1995) Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J Gen Virol 76(Pt 1):131\u2013138","journal-title":"J Gen Virol"},{"issue":"18","key":"330_CR32","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1128\/JVI.76.18.9556-9561.2002","volume":"76","author":"SY Chen","year":"2002","unstructured":"Chen SY et al (2002) Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J Virol 76(18):9556\u20139561","journal-title":"J Virol"},{"issue":"2","key":"330_CR33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ijc.20594","volume":"113","author":"F Chen","year":"2005","unstructured":"Chen F et al (2005) Epstein-Barr virus latent membrane 2A (LMP2A) down-regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines. Int J Cancer 113(2):284\u2013289","journal-title":"Int J Cancer"},{"issue":"3","key":"330_CR34","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1128\/JVI.02209-13","volume":"88","author":"HS Chen","year":"2014","unstructured":"Chen HS et al (2014) Epigenetic deregulation of the LMP1\/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site. J Virol 88(3):1703\u20131713","journal-title":"J Virol"},{"issue":"4","key":"330_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11262-024-02071-w","volume":"60","author":"Y Chen","year":"2024","unstructured":"Chen Y et al (2024) Study on the regulatory mechanism of latent membrane protein 2A on GCNT3 expression in nasopharyngeal carcinoma. Virus Genes 60(4):347\u2013356","journal-title":"Virus Genes"},{"issue":"2","key":"330_CR36","volume":"421","author":"T Cheng","year":"2022","unstructured":"Cheng T et al (2022) EBV promotes vascular mimicry of dormant cancer cells by potentiating stemness and EMT. Exp Cell Res 421(2):113403","journal-title":"Exp Cell Res"},{"issue":"5","key":"330_CR37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3858\/emm.2008.40.5.565","volume":"40","author":"NH Cho","year":"2008","unstructured":"Cho NH, Choi YK, Choi JK (2008) Multi-transmembrane protein K15 of Kaposi's sarcoma-associated herpesvirus targets Lyn kinase in the membrane raft and induces NFAT\/AP1 activities. Exp Mol Med 40(5):565\u2013573","journal-title":"Exp Mol Med"},{"issue":"1","key":"330_CR38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/JVI.74.1.436-446.2000","volume":"74","author":"JK Choi","year":"2000","unstructured":"Choi JK et al (2000) Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J Virol 74(1):436\u2013446","journal-title":"J Virol"},{"issue":"1","key":"330_CR39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/cei.12250","volume":"176","author":"E Colombo","year":"2014","unstructured":"Colombo E et al (2014) Skewed B cell differentiation affects lymphoid organogenesis but not T cell-mediated autoimmunity. Clin Exp Immunol 176(1):58\u201365","journal-title":"Clin Exp Immunol"},{"key":"330_CR40","doi-asserted-by":"crossref","unstructured":"Correia S et al (2018) Sequence variation of Epstein-Barr virus: viral types, geography, codon usage, and diseases. J Virol 92(22)","DOI":"10.1128\/JVI.01132-18"},{"issue":"1","key":"330_CR41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2012.05.003","volume":"95","author":"JL Dargart","year":"2012","unstructured":"Dargart JL et al (2012) Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A. Antivir Res 95(1):49\u201356","journal-title":"Antivir Res"},{"issue":"2","key":"330_CR42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2001.1142","volume":"289","author":"CW Dawson","year":"2001","unstructured":"Dawson CW et al (2001) The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1. Virology 289(2):192\u2013207","journal-title":"Virology"},{"issue":"2","key":"330_CR43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","volume":"177","author":"EM Deacon","year":"1993","unstructured":"Deacon EM et al (1993) Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 177(2):339\u2013349","journal-title":"J Exp Med"},{"key":"330_CR44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2015.05.007","volume":"484","author":"A Deb Pal","year":"2015","unstructured":"Deb Pal A, Banerjee S (2015) Epstein-Barr virus latent membrane protein 2A mediated activation of Sonic Hedgehog pathway induces HLA class Ia downregulation in gastric cancer cells. Virology 484:22\u201332","journal-title":"Virology"},{"key":"330_CR45","doi-asserted-by":"crossref","unstructured":"DeKroon RM et al (2018) Global proteomic changes induced by the Epstein-Barr virus oncoproteins latent membrane protein 1 and 2A. MBio 9(3)","DOI":"10.1128\/mBio.00959-18"},{"issue":"4","key":"330_CR46","volume":"6","author":"ZM Du","year":"2011","unstructured":"Du ZM et al (2011) Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 6(4):e19137","journal-title":"PLoS One"},{"issue":"10","key":"330_CR47","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/hed.21953","volume":"34","author":"ZM Du","year":"2012","unstructured":"Du ZM et al (2012) Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma. Head Neck 34(10):1456\u20131464","journal-title":"Head Neck"},{"issue":"6","key":"330_CR48","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-21-2292","volume":"82","author":"X Duan","year":"2022","unstructured":"Duan X et al (2022) EBV infection in epithelial malignancies induces resistance to antitumor natural killer cells via F3-mediated platelet aggregation. Cancer Res 82(6):1070\u20131083","journal-title":"Cancer Res"},{"issue":"1","key":"330_CR49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1074-7613(01)00089-9","volume":"14","author":"ML Dykstra","year":"2001","unstructured":"Dykstra ML, Longnecker R, Pierce SK (2001) Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14(1):57\u201367","journal-title":"Immunity"},{"issue":"3","key":"330_CR50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.194.3.255","volume":"194","author":"N Engels","year":"2001","unstructured":"Engels N et al (2001) Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J Exp Med 194(3):255\u2013264","journal-title":"J Exp Med"},{"key":"330_CR51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1478-811X-10-9","volume":"10","author":"N Engels","year":"2012","unstructured":"Engels N et al (2012) Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B cell antigen receptor-like activation signal. Cell Commun Signal 10:9","journal-title":"Cell Commun Signal"},{"issue":"4","key":"330_CR52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2013-07-517649","volume":"123","author":"K Fish","year":"2014","unstructured":"Fish K, Chen J, Longnecker R (2014) Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma. Blood 123(4):530\u2013540","journal-title":"Blood"},{"issue":"23","key":"330_CR53","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2017-07-796821","volume":"130","author":"K Fish","year":"2017","unstructured":"Fish K et al (2017) EBV latent membrane protein 2A orchestrates p27(kip1) degradation via Cks1 to accelerate MYC-driven lymphoma in mice. Blood 130(23):2516\u20132526","journal-title":"Blood"},{"issue":"42","key":"330_CR54","doi-asserted-by":"crossref","first-page":"26318","DOI":"10.1073\/pnas.2007946117","volume":"117","author":"K Fish","year":"2020","unstructured":"Fish K et al (2020) Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A. Proc Natl Acad Sci USA 117(42):26318\u201326327","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"330_CR55","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1128\/JVI.02203-13","volume":"87","author":"JA Fotheringham","year":"2013","unstructured":"Fotheringham JA, Raab-Traub N (2013) Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs. J Virol 87(24):13803\u201313815","journal-title":"J Virol"},{"issue":"13","key":"330_CR56","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1128\/JVI.03371-14","volume":"89","author":"JA Fotheringham","year":"2015","unstructured":"Fotheringham JA, Raab-Traub N (2015) Epstein-Barr virus latent membrane protein 2 induces autophagy to promote abnormal acinus formation. J Virol 89(13):6940\u20136944","journal-title":"J Virol"},{"issue":"30","key":"330_CR57","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/onc.2010.175","volume":"29","author":"JA Fotheringham","year":"2010","unstructured":"Fotheringham JA, Mazzucca S, Raab-Traub N (2010) Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation. Oncogene 29(30):4287\u20134296","journal-title":"Oncogene"},{"issue":"19","key":"330_CR58","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1128\/JVI.00853-12","volume":"86","author":"JA Fotheringham","year":"2012","unstructured":"Fotheringham JA, Coalson NE, Raab-Traub N (2012) Epstein-Barr virus latent membrane protein-2A induces ITAM\/Syk- and Akt-dependent epithelial migration through alphav-integrin membrane translocation. J Virol 86(19):10308\u201310320","journal-title":"J Virol"},{"issue":"2","key":"330_CR59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/viro.1997.8690","volume":"235","author":"S Fruehling","year":"1997","unstructured":"Fruehling S, Longnecker R (1997) The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235(2):241\u2013251","journal-title":"Virology"},{"issue":"9","key":"330_CR60","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1128\/jvi.70.9.6216-6226.1996","volume":"70","author":"S Fruehling","year":"1996","unstructured":"Fruehling S et al (1996) Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J Virol 70(9):6216\u20136226","journal-title":"J Virol"},{"issue":"10","key":"330_CR61","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.72.10.7796-7806.1998","volume":"72","author":"S Fruehling","year":"1998","unstructured":"Fruehling S et al (1998) Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J Virol 72(10):7796\u20137806","journal-title":"J Virol"},{"issue":"9","key":"330_CR62","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/JVI.03714-13","volume":"88","author":"M Fukuda","year":"2014","unstructured":"Fukuda M, Kawaguchi Y (2014) Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation. J Virol 88(9):5189\u20135194","journal-title":"J Virol"},{"issue":"4","key":"330_CR63","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/JVI.78.4.1697-1705.2004","volume":"78","author":"M Fukuda","year":"2004","unstructured":"Fukuda M, Longnecker R (2004) Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase\/Akt pathway. J Virol 78(4):1697\u20131705","journal-title":"J Virol"},{"issue":"13","key":"330_CR64","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1128\/JVI.79.13.8655-8660.2005","volume":"79","author":"M Fukuda","year":"2005","unstructured":"Fukuda M, Longnecker R (2005) Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J Virol 79(13):8655\u20138660","journal-title":"J Virol"},{"issue":"17","key":"330_CR65","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1128\/JVI.00537-07","volume":"81","author":"M Fukuda","year":"2007","unstructured":"Fukuda M, Longnecker R (2007) Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras\/PI3-K\/Akt pathway. J Virol 81(17):9299\u20139306","journal-title":"J Virol"},{"issue":"1","key":"330_CR66","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1038\/s41598-017-09540-3","volume":"7","author":"MR Gainullin","year":"2017","unstructured":"Gainullin MR et al (2017) Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells. Sci Rep 7(1):9012","journal-title":"Sci Rep"},{"issue":"8","key":"330_CR67","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1128\/JVI.73.8.6953-6963.1999","volume":"73","author":"M Glenn","year":"1999","unstructured":"Glenn M et al (1999) Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol 73(8):6953\u20136963","journal-title":"J Virol"},{"issue":"2","key":"330_CR68","first-page":"2613","volume":"16","author":"W Gong","year":"2018","unstructured":"Gong W et al (2018) Dihydroartemisinin suppresses the proliferation of Epstein-Barr virus-associated gastric carcinoma cells via downregulation of latent membrane protein 2A. Oncol Lett 16(2):2613\u20132619","journal-title":"Oncol Lett"},{"key":"330_CR69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13027-020-00292-w","volume":"15","author":"M Granai","year":"2020","unstructured":"Granai M et al (2020) Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. Infect Agent Cancer 15:28","journal-title":"Infect Agent Cancer"},{"issue":"22","key":"330_CR70","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.1128\/JVI.01873-15","volume":"89","author":"G Gregorovic","year":"2015","unstructured":"Gregorovic G et al (2015) Epstein-Barr viruses (EBVs) deficient in EBV-encoded RNAs have higher levels of latent membrane protein 2 RNA expression in Lymphoblastoid cell lines and efficiently establish persistent infections in humanized mice. J Virol 89(22):11711\u201311714","journal-title":"J Virol"},{"issue":"11","key":"330_CR71","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","volume":"174","author":"AJ Gross","year":"2005","unstructured":"Gross AJ et al (2005) EBV and systemic lupus erythematosus: a new perspective. J Immunol 174(11):6599\u20136607","journal-title":"J Immunol"},{"issue":"7","key":"330_CR72","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1182\/blood-2007-03-080309","volume":"111","author":"I Guasparri","year":"2008","unstructured":"Guasparri I, Bubman D, Cesarman E (2008) EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111(7):3813\u20133820","journal-title":"Blood"},{"issue":"3","key":"330_CR73","volume":"7","author":"J Han","year":"2012","unstructured":"Han J et al (2012) Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS One 7(3):e34276","journal-title":"PLoS One"},{"issue":"43","key":"330_CR74","doi-asserted-by":"crossref","first-page":"37368","DOI":"10.1074\/jbc.M111.255125","volume":"286","author":"O Hatton","year":"2011","unstructured":"Hatton O et al (2011) Syk activation of phosphatidylinositol 3-kinase\/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas. J Biol Chem 286(43):37368\u201337378","journal-title":"J Biol Chem"},{"issue":"4","key":"330_CR75","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/ajt.12137","volume":"13","author":"O Hatton","year":"2013","unstructured":"Hatton O et al (2013) Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. Am J Transplant 13(4):883\u2013890","journal-title":"Am J Transplant"},{"issue":"2","key":"330_CR76","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/path.1569","volume":"203","author":"N Heussinger","year":"2004","unstructured":"Heussinger N et al (2004) Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J Pathol 203(2):696\u2013699","journal-title":"J Pathol"},{"issue":"8","key":"330_CR77","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1073\/pnas.081075298","volume":"98","author":"M Higuchi","year":"2001","unstructured":"Higuchi M, Izumi KM, Kieff E (2001) Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc Natl Acad Sci USA 98(8):4675\u20134680","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"330_CR78","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/0008-5472.CAN-07-3027","volume":"68","author":"R Hino","year":"2008","unstructured":"Hino R et al (2008) Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res 68(5):1427\u20131435","journal-title":"Cancer Res"},{"key":"330_CR79","doi-asserted-by":"crossref","unstructured":"Ho JWY et al (2023) Comprehensive profiling of EBV gene expression and promoter methylation reveals latency II viral infection and sporadic abortive lytic activation in peripheral T-cell lymphomas. Viruses 15(2)","DOI":"10.3390\/v15020423"},{"issue":"1","key":"330_CR80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.virol.2008.11.025","volume":"385","author":"FC Hsiao","year":"2009","unstructured":"Hsiao FC et al (2009) EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology 385(1):261\u2013266","journal-title":"Virology"},{"issue":"1","key":"330_CR81","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/viro.1999.0166","volume":"268","author":"M Ikeda","year":"2000","unstructured":"Ikeda M et al (2000) The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology 268(1):178\u2013191","journal-title":"Virology"},{"issue":"12","key":"330_CR82","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1128\/JVI.75.12.5711-5718.2001","volume":"75","author":"M Ikeda","year":"2001","unstructured":"Ikeda M, Ikeda A, Longnecker R (2001) PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. J Virol 75(12):5711\u20135718","journal-title":"J Virol"},{"issue":"9","key":"330_CR83","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1128\/JVI.77.9.5529-5534.2003","volume":"77","author":"A Ikeda","year":"2003","unstructured":"Ikeda A et al (2003) Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling. J Virol 77(9):5529\u20135534","journal-title":"J Virol"},{"issue":"9","key":"330_CR84","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.4049\/jimmunol.172.9.5329","volume":"172","author":"A Ikeda","year":"2004","unstructured":"Ikeda A et al (2004) Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development. J Immunol 172(9):5329\u20135337","journal-title":"J Immunol"},{"issue":"14","key":"330_CR85","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/bloodadvances.2022007695","volume":"6","author":"M Ikeda","year":"2022","unstructured":"Ikeda M et al (2022) Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis. Blood Adv 6(14):4283\u20134296","journal-title":"Blood Adv"},{"issue":"19","key":"330_CR86","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","volume":"91","author":"S Imai","year":"1994","unstructured":"Imai S et al (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91(19):9131\u20139135","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 5","key":"330_CR87","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1099\/vir.0.049221-0","volume":"94","author":"R Incrocci","year":"2013","unstructured":"Incrocci R, McCormack M, Swanson-Mungerson M (2013) Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas. J Gen Virol 94(Pt 5):1127\u20131133","journal-title":"J Gen Virol"},{"issue":"2","key":"330_CR88","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cellimm.2015.08.001","volume":"297","author":"R Incrocci","year":"2015","unstructured":"Incrocci R et al (2015) Epstein-Barr virus latent membrane protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: role of Lyn\/Syk activation. Cell Immunol 297(2):108\u2013119","journal-title":"Cell Immunol"},{"key":"330_CR89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.virol.2016.10.015","volume":"500","author":"R Incrocci","year":"2017","unstructured":"Incrocci R et al (2017) Epstein-Barr virus latent membrane protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3. Virology 500:96\u2013102","journal-title":"Virology"},{"issue":"5","key":"330_CR90","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jmv.25381","volume":"91","author":"R Incrocci","year":"2019","unstructured":"Incrocci R et al (2019) Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-kappaB in B-cell lymphomas to increase MIP-1alpha production. J Med Virol 91(5):845\u2013855","journal-title":"J Med Virol"},{"key":"330_CR91","doi-asserted-by":"crossref","unstructured":"Incrocci R et al (2024) Epstein-Barr virus latent membrane protein 2A (LMP2A) enhances ATP production in B cell tumors through mTOR and HIF-1alpha. Int J Mol Sci 25(7)","DOI":"10.3390\/ijms25073944"},{"issue":"40","key":"330_CR92","doi-asserted-by":"crossref","first-page":"34133","DOI":"10.1074\/jbc.M507831200","volume":"280","author":"RJ Ingham","year":"2005","unstructured":"Ingham RJ et al (2005) The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor. J Biol Chem 280(40):34133\u201334142","journal-title":"J Biol Chem"},{"issue":"14","key":"330_CR93","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1128\/JVI.01089-13","volume":"87","author":"D Iwakiri","year":"2013","unstructured":"Iwakiri D, Minamitani T, Samanta M (2013) Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation. J Virol 87(14):8227\u20138234","journal-title":"J Virol"},{"issue":"2","key":"330_CR94","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11262-007-0116-x","volume":"35","author":"A Jansson","year":"2007","unstructured":"Jansson A et al (2007) Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation. Virus Genes 35(2):203\u2013214","journal-title":"Virus Genes"},{"key":"330_CR95","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198399","volume":"297","author":"Y Jiang","year":"2021","unstructured":"Jiang Y et al (2021) LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer. Virus Res 297:198399","journal-title":"Virus Res"},{"issue":"1","key":"330_CR96","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/jvi.69.1.253-262.1995","volume":"69","author":"E Johannsen","year":"1995","unstructured":"Johannsen E et al (1995) Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol 69(1):253\u2013262","journal-title":"J Virol"},{"key":"330_CR97","doi-asserted-by":"crossref","unstructured":"Johnson LR, Nalesnik MA, Swerdlow SH (2006) Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Am J Surg Pathol 30(12):1604\u20131612","DOI":"10.1097\/01.pas.0000213317.59176.d2"},{"issue":"20","key":"330_CR98","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1128\/JVI.78.20.10878-10887.2004","volume":"78","author":"RB Katzman","year":"2004","unstructured":"Katzman RB, Longnecker R (2004) LMP2A does not require palmitoylation to localize to buoyant complexes or for function. J Virol 78(20):10878\u201310887","journal-title":"J Virol"},{"issue":"5","key":"330_CR99","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","volume":"15","author":"Y Kaymaz","year":"2017","unstructured":"Kaymaz Y et al (2017) Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences. Mol Cancer Res 15(5):563\u2013576","journal-title":"Mol Cancer Res"},{"issue":"12","key":"330_CR100","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1128\/jvi.67.12.7634-7640.1993","volume":"67","author":"OJ Kim","year":"1993","unstructured":"Kim OJ, Yates JL (1993) Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture. J Virol 67(12):7634\u20137640","journal-title":"J Virol"},{"issue":"Pt 3","key":"330_CR101","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1099\/vir.0.045237-0","volume":"94","author":"DN Kim","year":"2013","unstructured":"Kim DN et al (2013) Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. J Gen Virol 94(Pt 3):497\u2013506","journal-title":"J Gen Virol"},{"issue":"1\u20132","key":"330_CR102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.imlet.2005.11.003","volume":"104","author":"LL Kis","year":"2006","unstructured":"Kis LL et al (2006) Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Immunol Lett 104(1\u20132):83\u201388","journal-title":"Immunol Lett"},{"issue":"2","key":"330_CR103","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1073\/pnas.0912920107","volume":"107","author":"LL Kis","year":"2010","unstructured":"Kis LL et al (2010) IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter. Proc Natl Acad Sci USA 107(2):872\u2013877","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"330_CR104","volume":"6","author":"QL Kong","year":"2010","unstructured":"Kong QL et al (2010) Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 6(6):e1000940","journal-title":"PLoS Pathog"},{"issue":"Pt 6","key":"330_CR105","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1099\/0022-1317-82-6-1451","volume":"82","author":"K Konishi","year":"2001","unstructured":"Konishi K et al (2001) Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J Gen Virol 82(Pt 6):1451\u20131456","journal-title":"J Gen Virol"},{"issue":"12","key":"330_CR106","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1128\/JVI.00174-12","volume":"86","author":"YY Lan","year":"2012","unstructured":"Lan YY et al (2012) Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK\/Fra-1-mediated induction of matrix metalloproteinase 9. J Virol 86(12):6656\u20136667","journal-title":"J Virol"},{"issue":"4","key":"330_CR107","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bbrc.2013.06.014","volume":"436","author":"YY Lan","year":"2013","unstructured":"Lan YY et al (2013) WW domain-containing oxidoreductase is involved in upregulation of matrix metalloproteinase 9 by Epstein-Barr virus latent membrane protein 2A. Biochem Biophys Res Commun 436(4):672\u2013676","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"330_CR108","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/j.1460-2075.1988.tb02874.x","volume":"7","author":"G Laux","year":"1988","unstructured":"Laux G, Perricaudet M, Farrell PJ (1988) A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J 7(3):769\u2013774","journal-title":"EMBO J"},{"issue":"Pt 11","key":"330_CR109","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1099\/0022-1317-70-11-3079","volume":"70","author":"G Laux","year":"1989","unstructured":"Laux G, Economou A, Farrell PJ (1989) The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region. J Gen Virol 70(Pt 11):3079\u20133084","journal-title":"J Gen Virol"},{"issue":"4","key":"330_CR110","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2007-07-100032","volume":"111","author":"DY Lee","year":"2008","unstructured":"Lee DY, Sugden B (2008) The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood 111(4):2280\u20132289","journal-title":"Blood"},{"issue":"4","key":"330_CR111","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2015.01.015","volume":"160","author":"N Lee","year":"2015","unstructured":"Lee N et al (2015) EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA. Cell 160(4):607\u2013618","journal-title":"Cell"},{"issue":"12","key":"330_CR112","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1073\/pnas.1601773113","volume":"113","author":"N Lee","year":"2016","unstructured":"Lee N et al (2016) EBV noncoding RNA EBER2 interacts with host RNA-binding proteins to regulate viral gene expression. Proc Natl Acad Sci USA 113(12):3221\u20133226","journal-title":"Proc Natl Acad Sci USA"},{"key":"330_CR113","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1038\/ncomms14121","volume":"8","author":"YY Li","year":"2017","unstructured":"Li YY et al (2017) Exome and genome sequencing of nasopharynx cancer identifies NF-kappaB pathway activating mutations. Nat Commun 8:14121","journal-title":"Nat Commun"},{"issue":"8","key":"330_CR114","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1111\/cas.14978","volume":"112","author":"W Li","year":"2021","unstructured":"Li W et al (2021) Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer. Cancer Sci 112(8):3349\u20133362","journal-title":"Cancer Sci"},{"issue":"2","key":"330_CR115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11262-023-01970-8","volume":"59","author":"Y Liang","year":"2023","unstructured":"Liang Y et al (2023) Nuclear respiratory factor 1 promotes the progression of EBV-associated gastric cancer and maintains EBV latent infection. Virus Genes 59(2):204\u2013214","journal-title":"Virus Genes"},{"issue":"4","key":"330_CR116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011939","volume":"20","author":"Y Liao","year":"2024","unstructured":"Liao Y et al (2024) Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression. PLoS Pathog 20(4):e1011939","journal-title":"PLoS Pathog"},{"issue":"20","key":"330_CR117","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1128\/JVI.01867-14","volume":"88","author":"Z Lin","year":"2014","unstructured":"Lin Z et al (2014a) Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction. J Virol 88(20):11872\u201311885","journal-title":"J Virol"},{"issue":"8","key":"330_CR118","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ng.3006","volume":"46","author":"DC Lin","year":"2014","unstructured":"Lin DC et al (2014b) The genomic landscape of nasopharyngeal carcinoma. Nat Genet 46(8):866\u2013871","journal-title":"Nat Genet"},{"issue":"14","key":"330_CR119","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2014-08-594689","volume":"125","author":"JH Lin","year":"2015","unstructured":"Lin JH et al (2015) Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1. Blood 125(14):2228\u20132238","journal-title":"Blood"},{"issue":"10","key":"330_CR120","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/mc.22389","volume":"55","author":"Z Lin","year":"2016","unstructured":"Lin Z et al (2016) S100A4 hypomethylation affects epithelial-mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma. Mol Carcinog 55(10):1467\u20131476","journal-title":"Mol Carcinog"},{"issue":"1","key":"330_CR121","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-018-06889-5","volume":"9","author":"W Lin","year":"2018","unstructured":"Lin W et al (2018a) Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma. Nat Commun 9(1):4663","journal-title":"Nat Commun"},{"issue":"12","key":"330_CR122","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00109-018-1704-z","volume":"96","author":"YT Lin","year":"2018","unstructured":"Lin YT et al (2018b) Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K\/Akt\/mTOR signaling in human nasopharyngeal carcinoma xenografts. J Mol Med (Berl) 96(12):1407\u20131418","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"330_CR123","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.18632\/oncotarget.6751","volume":"7","author":"Y Liu","year":"2016","unstructured":"Liu Y et al (2016) Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC). Oncotarget 7(4):4903\u20134914","journal-title":"Oncotarget"},{"key":"330_CR124","volume":"276","author":"W Liu","year":"2020","unstructured":"Liu W et al (2020) Dysregulation of FOXO transcription factors in Epstein-Barr virus-associated gastric carcinoma. Virus Res 276:197808","journal-title":"Virus Res"},{"key":"330_CR125","doi-asserted-by":"crossref","unstructured":"Liu J et al (2021) Epstein-Barr virus-encoded latent membrane protein 2A downregulates GCNT3 via the TGF-beta1\/Smad-mTORC1 signaling Axis. J Virol 95(10)","DOI":"10.1128\/JVI.02481-20"},{"issue":"6","key":"330_CR126","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11262-022-01925-5","volume":"58","author":"W Liu","year":"2022","unstructured":"Liu W et al (2022a) Transcriptome sequencing of LMP2A-transfected gastric cancer cells identifies potential biomarkers in EBV-associated gastric cancer. Virus Genes 58(6):515\u2013526","journal-title":"Virus Genes"},{"key":"330_CR127","volume":"315","author":"D Liu","year":"2022","unstructured":"Liu D et al (2022b) LMP2A inhibits the expression of KLF5 through the mTORC1 pathway in EBV-associated gastric carcinoma. Virus Res 315:198792","journal-title":"Virus Res"},{"issue":"Pt 9","key":"330_CR128","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1099\/0022-1317-81-9-2245","volume":"81","author":"L Longan","year":"2000","unstructured":"Longan L, Longnecker R (2000) Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia. J Gen Virol 81(Pt 9):2245\u20132252","journal-title":"J Gen Virol"},{"issue":"5","key":"330_CR129","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1128\/jvi.64.5.2319-2326.1990","volume":"64","author":"R Longnecker","year":"1990","unstructured":"Longnecker R, Kieff E (1990) A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol 64(5):2319\u20132326","journal-title":"J Virol"},{"issue":"11","key":"330_CR130","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1128\/jvi.66.11.6461-6469.1992","volume":"66","author":"R Longnecker","year":"1992","unstructured":"Longnecker R et al (1992) The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J Virol 66(11):6461\u20136469","journal-title":"J Virol"},{"issue":"4","key":"330_CR131","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/jvi.67.4.2006-2013.1993","volume":"67","author":"R Longnecker","year":"1993","unstructured":"Longnecker R et al (1993a) The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. J Virol 67(4):2006\u20132013","journal-title":"J Virol"},{"issue":"8","key":"330_CR132","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1128\/jvi.67.8.5068-5074.1993","volume":"67","author":"R Longnecker","year":"1993","unstructured":"Longnecker R et al (1993b) Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J Virol 67(8):5068\u20135074","journal-title":"J Virol"},{"issue":"2","key":"330_CR133","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/excr.2000.4900","volume":"257","author":"R Longnecker","year":"2000","unstructured":"Longnecker R et al (2000) WW- and SH3-domain interactions with Epstein-Barr virus LMP2A. Exp Cell Res 257(2):332\u2013340","journal-title":"Exp Cell Res"},{"issue":"13","key":"330_CR134","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1074\/jbc.M507305200","volume":"281","author":"J Lu","year":"2006","unstructured":"Lu J et al (2006) Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 281(13):8806\u20138814","journal-title":"J Biol Chem"},{"issue":"11","key":"330_CR135","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1593\/neo.09888","volume":"11","author":"RW Lung","year":"2009","unstructured":"Lung RW et al (2009) Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11(11):1174\u20131184","journal-title":"Neoplasia"},{"issue":"5","key":"330_CR136","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3748\/wjg.v11.i5.629","volume":"11","author":"B Luo","year":"2005","unstructured":"Luo B et al (2005) Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol 11(5):629\u2013633","journal-title":"World J Gastroenterol"},{"issue":"3","key":"330_CR137","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10637-012-9896-5","volume":"31","author":"BB Ma","year":"2013","unstructured":"Ma BB et al (2013) Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines. Investig New Drugs 31(3):567\u2013575","journal-title":"Investig New Drugs"},{"key":"330_CR138","doi-asserted-by":"crossref","unstructured":"Ma SD et al (2017a) Latent membrane protein 1 (LMP1) and LMP2A collaborate to promote Epstein-Barr virus-induced B cell lymphomas in a cord blood-humanized mouse model but are not essential. J Virol 91(7)","DOI":"10.1128\/JVI.01928-16"},{"issue":"5","key":"330_CR139","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.chom.2017.04.005","volume":"21","author":"Y Ma","year":"2017","unstructured":"Ma Y et al (2017b) CRISPR\/Cas9 screens reveal Epstein-Barr virus-transformed B cell host dependency factors. Cell Host Microbe 21(5):580\u2013591 e7","journal-title":"Cell Host Microbe"},{"issue":"10","key":"330_CR140","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","volume":"110","author":"C Mancao","year":"2007","unstructured":"Mancao C, Hammerschmidt W (2007) Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110(10):3715\u20133721","journal-title":"Blood"},{"issue":"13","key":"330_CR141","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","volume":"106","author":"C Mancao","year":"2005","unstructured":"Mancao C et al (2005) Rescue of \"crippled\" germinal center B cells from apoptosis by Epstein-Barr virus. Blood 106(13):4339\u20134344","journal-title":"Blood"},{"key":"330_CR142","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1746-1596-7-178","volume":"7","author":"Y Mao","year":"2012","unstructured":"Mao Y et al (2012) LMP1 and LMP2A are potential prognostic markers of extranodal NK\/T-cell lymphoma, nasal type (ENKTL). Diagn Pathol 7:178","journal-title":"Diagn Pathol"},{"issue":"22","key":"330_CR143","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/JVI.75.22.10941-10949.2001","volume":"75","author":"L Matskova","year":"2001","unstructured":"Matskova L et al (2001) C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal. J Virol 75(22):10941\u201310949","journal-title":"J Virol"},{"issue":"34","key":"330_CR144","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1038\/sj.onc.1210298","volume":"26","author":"LV Matskova","year":"2007","unstructured":"Matskova LV et al (2007) The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein. Oncogene 26(34):4908\u20134917","journal-title":"Oncogene"},{"issue":"Pt 9","key":"330_CR145","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1099\/vir.0.011627-0","volume":"90","author":"JE McLaren","year":"2009","unstructured":"McLaren JE et al (2009) STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells. J Gen Virol 90(Pt 9):2239\u20132250","journal-title":"J Gen Virol"},{"issue":"11","key":"330_CR146","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1128\/jvi.68.11.7497-7506.1994","volume":"68","author":"C Meitinger","year":"1994","unstructured":"Meitinger C et al (1994) Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element. J Virol 68(11):7497\u20137506","journal-title":"J Virol"},{"issue":"1","key":"330_CR147","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/viro.2001.1187","volume":"291","author":"M Merchant","year":"2001","unstructured":"Merchant M, Longnecker R (2001) LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways. Virology 291(1):46\u201354","journal-title":"Virology"},{"issue":"19","key":"330_CR148","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1128\/JVI.74.19.9115-9124.2000","volume":"74","author":"M Merchant","year":"2000","unstructured":"Merchant M, Caldwell RG, Longnecker R (2000) The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol 74(19):9115\u20139124","journal-title":"J Virol"},{"issue":"6","key":"330_CR149","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/jvi.67.6.3087-3094.1993","volume":"67","author":"CL Miller","year":"1993","unstructured":"Miller CL, Longnecker R, Kieff E (1993) Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol 67(6):3087\u20133094","journal-title":"J Virol"},{"issue":"2\u20133","key":"330_CR150","first-page":"128","volume":"3","author":"CL Miller","year":"1994","unstructured":"Miller CL et al (1994) Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect Agents Dis 3(2\u20133):128\u2013136","journal-title":"Infect Agents Dis"},{"issue":"2","key":"330_CR151","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1074-7613(95)80040-9","volume":"2","author":"CL Miller","year":"1995","unstructured":"Miller CL et al (1995) Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2(2):155\u2013166","journal-title":"Immunity"},{"issue":"37","key":"330_CR152","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1073\/pnas.1514484112","volume":"112","author":"T Minamitani","year":"2015","unstructured":"Minamitani T et al (2015) Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proc Natl Acad Sci USA 112(37):11612\u201311617","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"330_CR153","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1073\/pnas.1701836114","volume":"114","author":"T Minamitani","year":"2017","unstructured":"Minamitani T et al (2017) Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease. Proc Natl Acad Sci USA 114(18):4751\u20134756","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"330_CR154","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/jvi.71.7.4882-4891.1997","volume":"71","author":"EM Miyashita","year":"1997","unstructured":"Miyashita EM et al (1997) Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71(7):4882\u20134891","journal-title":"J Virol"},{"issue":"15","key":"330_CR155","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1128\/JVI.77.15.8555-8561.2003","volume":"77","author":"CA Moody","year":"2003","unstructured":"Moody CA et al (2003) Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence. J Virol 77(15):8555\u20138561","journal-title":"J Virol"},{"issue":"9","key":"330_CR156","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/JVI.79.9.5499-5506.2005","volume":"79","author":"CA Moody","year":"2005","unstructured":"Moody CA et al (2005) Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A. J Virol 79(9):5499\u20135506","journal-title":"J Virol"},{"issue":"4","key":"330_CR157","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/JVI.79.4.2375-2382.2005","volume":"79","author":"JA Morrison","year":"2005","unstructured":"Morrison JA, Raab-Traub N (2005) Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of beta-catenin signaling. J Virol 79(4):2375\u20132382","journal-title":"J Virol"},{"issue":"22","key":"330_CR158","doi-asserted-by":"crossref","first-page":"12276","DOI":"10.1128\/JVI.77.22.12276-12284.2003","volume":"77","author":"JA Morrison","year":"2003","unstructured":"Morrison JA, Klingelhutz AJ, Raab-Traub N (2003) Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol 77(22):12276\u201312284","journal-title":"J Virol"},{"issue":"9","key":"330_CR159","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1084\/jem.20181953","volume":"216","author":"EK Moser","year":"2019","unstructured":"Moser EK et al (2019) The E3 ubiquitin ligase Itch restricts antigen-driven B cell responses. J Exp Med 216(9):2170\u20132183","journal-title":"J Exp Med"},{"issue":"5","key":"330_CR160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000106462","volume":"50","author":"M Nagamine","year":"2007","unstructured":"Nagamine M et al (2007) Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK\/T cell lymphoma patients. Intervirology 50(5):319\u2013322","journal-title":"Intervirology"},{"issue":"1\u20132","key":"330_CR161","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virusres.2013.03.009","volume":"174","author":"T Nakaya","year":"2013","unstructured":"Nakaya T et al (2013) Enrichment of stem-like cell population comprises transformation ability of Epstein-Barr virus latent membrane protein 2A for non-transformed cells. Virus Res 174(1\u20132):108\u2013115","journal-title":"Virus Res"},{"issue":"19","key":"330_CR162","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1038\/sj.emboj.7601853","volume":"26","author":"A Nanbo","year":"2007","unstructured":"Nanbo A, Sugden A, Sugden B (2007) The coupling of synthesis and partitioning of EBV'S plasmid replicon is revealed in live cells. EMBO J 26(19):4252\u20134262","journal-title":"EMBO J"},{"issue":"4","key":"330_CR163","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood.V90.4.1664","volume":"90","author":"G Niedobitek","year":"1997","unstructured":"Niedobitek G et al (1997) Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 90(4):1664\u20131672","journal-title":"Blood"},{"issue":"17","key":"330_CR164","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1128\/JVI.77.17.9359-9368.2003","volume":"77","author":"S Ning","year":"2003","unstructured":"Ning S et al (2003) Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. J Virol 77(17):9359\u20139368","journal-title":"J Virol"},{"issue":"7517","key":"330_CR165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202\u2013209","journal-title":"Nature"},{"issue":"49","key":"330_CR166","doi-asserted-by":"crossref","first-page":"42524","DOI":"10.1074\/jbc.M111.271734","volume":"286","author":"C Noda","year":"2011","unstructured":"Noda C et al (2011) Identification and characterization of CCAAT enhancer-binding protein (C\/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1. J Biol Chem 286(49):42524\u201342533","journal-title":"J Biol Chem"},{"issue":"4","key":"330_CR167","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.21873\/anticanres.16939","volume":"44","author":"MH Noh","year":"2024","unstructured":"Noh MH et al (2024) Role of Peroxiredoxin 1 induced by Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 44(4):1425\u20131440","journal-title":"Anticancer Res"},{"issue":"2","key":"330_CR168","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.virol.2003.12.005","volume":"320","author":"ST Oh","year":"2004","unstructured":"Oh ST et al (2004) A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 320(2):330\u2013336","journal-title":"Virology"},{"issue":"7","key":"330_CR169","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/carcin\/bgu069","volume":"35","author":"AD Pal","year":"2014","unstructured":"Pal AD et al (2014) Epstein-Barr virus latent membrane protein-2A alters mitochondrial dynamics promoting cellular migration mediated by Notch signaling pathway. Carcinogenesis 35(7):1592\u20131601","journal-title":"Carcinogenesis"},{"issue":"12","key":"330_CR170","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1462-5822.2008.01221.x","volume":"10","author":"YR Pan","year":"2008","unstructured":"Pan YR et al (2008) Epstein-Barr virus latent membrane protein 2A upregulates UDP-glucose dehydrogenase gene expression via ERK and PI3K\/Akt pathway. Cell Microbiol 10(12):2447\u20132460","journal-title":"Cell Microbiol"},{"issue":"6","key":"330_CR171","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/jvi.71.6.4752-4760.1997","volume":"71","author":"CG Panousis","year":"1997","unstructured":"Panousis CG, Rowe DT (1997) Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J Virol 71(6):4752\u20134760","journal-title":"J Virol"},{"issue":"24","key":"330_CR172","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1128\/JVI.79.24.15430-15442.2005","volume":"79","author":"DM Pegtel","year":"2005","unstructured":"Pegtel DM et al (2005) Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 79(24):15430\u201315442","journal-title":"J Virol"},{"key":"330_CR173","doi-asserted-by":"crossref","unstructured":"Pich D et al (2019) First days in the life of naive human B lymphocytes infected with Epstein-Barr virus. MBio 10(5)","DOI":"10.1128\/mBio.01723-19"},{"issue":"8","key":"330_CR174","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1128\/JVI.73.8.6646-6660.1999","volume":"73","author":"LJ Poole","year":"1999","unstructured":"Poole LJ et al (1999) Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 73(8):6646\u20136660","journal-title":"J Virol"},{"issue":"3","key":"330_CR175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.4245","volume":"231","author":"RJ Port","year":"2013","unstructured":"Port RJ et al (2013) Epstein-Barr virus induction of the hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells. J Pathol 231(3):367\u2013377","journal-title":"J Pathol"},{"issue":"1","key":"330_CR176","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/JVI.77.1.105-114.2003","volume":"77","author":"T Portis","year":"2003","unstructured":"Portis T, Longnecker R (2003) Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J Virol 77(1):105\u2013114","journal-title":"J Virol"},{"issue":"53","key":"330_CR177","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1038\/sj.onc.1207905","volume":"23","author":"T Portis","year":"2004","unstructured":"Portis T, Longnecker R (2004a) Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras\/PI3K\/Akt pathway. Oncogene 23(53):8619\u20138628","journal-title":"Oncogene"},{"issue":"2","key":"330_CR178","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.virol.2003.09.017","volume":"318","author":"T Portis","year":"2004","unstructured":"Portis T, Longnecker R (2004b) Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation. Virology 318(2):524\u2013533","journal-title":"Virology"},{"issue":"12","key":"330_CR179","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1182\/blood-2003-04-1018","volume":"102","author":"T Portis","year":"2003","unstructured":"Portis T, Dyck P, Longnecker R (2003) Epstein-Barr virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in reed-Sternberg cells of Hodgkin lymphoma. Blood 102(12):4166\u20134178","journal-title":"Blood"},{"key":"330_CR180","volume":"272","author":"YF Qi","year":"2019","unstructured":"Qi YF et al (2019) EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer. Virus Res 272:197735","journal-title":"Virus Res"},{"issue":"10","key":"330_CR181","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00705-022-05511-w","volume":"167","author":"N Qin","year":"2022","unstructured":"Qin N et al (2022) Maintenance of Epstein-Barr virus latency through interaction of LMP2A with CXCR4. Arch Virol 167(10):1947\u20131959","journal-title":"Arch Virol"},{"issue":"6","key":"330_CR182","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004906","volume":"11","author":"C Rancan","year":"2015","unstructured":"Rancan C et al (2015) Latent membrane protein LMP2A impairs recognition of EBV-infected cells by CD8+ T cells. PLoS Pathog 11(6):e1004906","journal-title":"PLoS Pathog"},{"issue":"Pt 5","key":"330_CR183","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1099\/vir.0.82790-0","volume":"88","author":"MP Rechsteiner","year":"2007","unstructured":"Rechsteiner MP et al (2007) Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. J Gen Virol 88(Pt 5):1454\u20131459","journal-title":"J Gen Virol"},{"issue":"4","key":"330_CR184","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/JVI.01723-07","volume":"82","author":"MP Rechsteiner","year":"2008","unstructured":"Rechsteiner MP et al (2008) Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J Virol 82(4):1739\u20131747","journal-title":"J Virol"},{"issue":"6","key":"330_CR185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2217\/fon-2016-0475","volume":"13","author":"J Ribeiro","year":"2017","unstructured":"Ribeiro J et al (2017) Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review. Future Oncol 13(6):567\u2013579","journal-title":"Future Oncol"},{"issue":"10","key":"330_CR186","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1128\/JVI.73.10.8867-8872.1999","volume":"73","author":"P Rivailler","year":"1999","unstructured":"Rivailler P, Quink C, Wang F (1999) Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus. J Virol 73(10):8867\u20138872","journal-title":"J Virol"},{"issue":"23","key":"330_CR187","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1128\/JVI.76.23.12055-12068.2002","volume":"76","author":"P Rivailler","year":"2002","unstructured":"Rivailler P, Cho YG, Wang F (2002a) Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J Virol 76(23):12055\u201312068","journal-title":"J Virol"},{"issue":"1","key":"330_CR188","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/JVI.76.1.421-426.2002","volume":"76","author":"P Rivailler","year":"2002","unstructured":"Rivailler P et al (2002b) Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J Virol 76(1):421\u2013426","journal-title":"J Virol"},{"issue":"4","key":"330_CR189","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s007050050113","volume":"142","author":"R Rochford","year":"1997","unstructured":"Rochford R et al (1997) In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2). Arch Virol 142(4):707\u2013720","journal-title":"Arch Virol"},{"issue":"5","key":"330_CR190","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.113","volume":"5","author":"M Rossi","year":"2014","unstructured":"Rossi M et al (2014) High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. Cell Death Dis 5(5):e1203","journal-title":"Cell Death Dis"},{"issue":"1","key":"330_CR191","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/JVI.01302-06","volume":"81","author":"M Rovedo","year":"2007","unstructured":"Rovedo M, Longnecker R (2007) Epstein-Barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity. J Virol 81(1):84\u201394","journal-title":"J Virol"},{"issue":"17","key":"330_CR192","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1128\/JVI.00843-08","volume":"82","author":"M Rovedo","year":"2008","unstructured":"Rovedo M, Longnecker R (2008) Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn. J Virol 82(17):8520\u20138528","journal-title":"J Virol"},{"issue":"20","key":"330_CR193","doi-asserted-by":"crossref","first-page":"12065","DOI":"10.1128\/JVI.01431-14","volume":"88","author":"M Rowe","year":"2014","unstructured":"Rowe M, Raithatha S, Shannon-Lowe C (2014) Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. J Virol 88(20):12065\u201312076","journal-title":"J Virol"},{"issue":"1","key":"330_CR194","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1025124519068","volume":"27","author":"D Salamon","year":"2003","unstructured":"Salamon D et al (2003) High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 27(1):57\u201366","journal-title":"Virus Genes"},{"issue":"6","key":"330_CR195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009635","volume":"17","author":"N Samarina","year":"2021","unstructured":"Samarina N et al (2021) Recruitment of phospholipase Cgamma1 to the non-structural membrane protein pK15 of Kaposi sarcoma-associated herpesvirus promotes its Src-dependent phosphorylation. PLoS Pathog 17(6):e1009635","journal-title":"PLoS Pathog"},{"issue":"2","key":"330_CR196","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/jvi.63.2.933-937.1989","volume":"63","author":"J Sample","year":"1989","unstructured":"Sample J, Liebowitz D, Kieff E (1989) Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol 63(2):933\u2013937","journal-title":"J Virol"},{"issue":"Pt 3","key":"330_CR197","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/vir.0.80440-0","volume":"86","author":"E Schaadt","year":"2005","unstructured":"Schaadt E et al (2005) Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J Gen Virol 86(Pt 3):551\u2013559","journal-title":"J Gen Virol"},{"issue":"6","key":"330_CR198","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1128\/JVI.73.6.4767-4775.1999","volume":"73","author":"F Scholle","year":"1999","unstructured":"Scholle F, Longnecker R, Raab-Traub N (1999) Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase. J Virol 73(6):4767\u20134775","journal-title":"J Virol"},{"issue":"22","key":"330_CR199","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1128\/JVI.74.22.10681-10689.2000","volume":"74","author":"F Scholle","year":"2000","unstructured":"Scholle F, Bendt KM, Raab-Traub N (2000) Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74(22):10681\u201310689","journal-title":"J Virol"},{"issue":"2","key":"330_CR200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/viro.2001.1197","volume":"291","author":"F Scholle","year":"2001","unstructured":"Scholle F, Longnecker R, Raab-Traub N (2001) Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells. Virology 291(2):208\u2013214","journal-title":"Virology"},{"issue":"1","key":"330_CR201","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.febslet.2006.11.078","volume":"581","author":"MD Seo","year":"2007","unstructured":"Seo MD et al (2007) Identification of the WW domain-interaction sites in the unstructured N-terminal domain of EBV LMP 2A. FEBS Lett 581(1):65\u201370","journal-title":"FEBS Lett"},{"key":"330_CR202","doi-asserted-by":"crossref","unstructured":"Seo MD et al (2021) Molecular interactions between two LMP2A PY motifs of EBV and WW domains of E3 ubiquitin ligase AIP4. Life (Basel) 11(5)","DOI":"10.3390\/life11050379"},{"issue":"44","key":"330_CR203","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1038\/onc.2009.249","volume":"28","author":"KM Shah","year":"2009","unstructured":"Shah KM et al (2009) The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene 28(44):3903\u20133914","journal-title":"Oncogene"},{"key":"330_CR204","doi-asserted-by":"crossref","unstructured":"Shair KH, Raab-Traub N (2012) Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma. MBio 3(5)","DOI":"10.1128\/mBio.00288-12"},{"issue":"9","key":"330_CR205","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1128\/JVI.07035-11","volume":"86","author":"KH Shair","year":"2012","unstructured":"Shair KH et al (2012) Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model. J Virol 86(9):5352\u20135365","journal-title":"J Virol"},{"issue":"1","key":"330_CR206","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jmv.25579","volume":"92","author":"Q Shi","year":"2020","unstructured":"Shi Q et al (2020) Latent membrane protein 2A inhibits expression level of Smad2 through regulating miR-155-5p in EBV-associated gastric cancer cell lines. J Med Virol 92(1):96\u2013106","journal-title":"J Med Virol"},{"issue":"4","key":"330_CR207","first-page":"769","volume":"140","author":"D Shibata","year":"1992","unstructured":"Shibata D, Weiss LM (1992) Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140(4):769\u2013774","journal-title":"Am J Pathol"},{"key":"330_CR208","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1471-2407-10-425","volume":"10","author":"JY Shin","year":"2010","unstructured":"Shin JY et al (2010) LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells. BMC Cancer 10:425","journal-title":"BMC Cancer"},{"issue":"2","key":"330_CR209","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.virol.2008.03.033","volume":"377","author":"CA Siler","year":"2008","unstructured":"Siler CA, Raab-Traub N (2008) Rhesus lymphocryptovirus latent membrane protein 2A activates beta-catenin signaling and inhibits differentiation in epithelial cells. Virology 377(2):273\u2013279","journal-title":"Virology"},{"issue":"1","key":"330_CR210","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41598-020-62081-0","volume":"10","author":"S Singh","year":"2020","unstructured":"Singh S, Banerjee S (2020) Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A\/B surface expression in LMP2A-positive epithelial carcinoma cell lines. Sci Rep 10(1):5415","journal-title":"Sci Rep"},{"issue":"8","key":"330_CR211","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1600-0854.2006.00450.x","volume":"7","author":"MD Snyder","year":"2006","unstructured":"Snyder MD, Pierce SK (2006) A mutation in Epstein-Barr virus LMP2A reveals a role for phospholipase D in B-cell antigen receptor trafficking. Traffic 7(8):993\u20131006","journal-title":"Traffic"},{"key":"330_CR212","doi-asserted-by":"crossref","unstructured":"Sora RP, Ikeda M, Longnecker R (2019) Two pathways of p27(Kip1) degradation are required for murine lymphoma driven by Myc and EBV latent membrane protein 2A. MBio 10(2)","DOI":"10.1128\/mBio.00548-19"},{"key":"330_CR213","first-page":"10","volume":"10","author":"ED SoRelle","year":"2021","unstructured":"SoRelle ED et al (2021) Single-cell RNA-seq reveals transcriptomic heterogeneity mediated by host-pathogen dynamics in lymphoblastoid cell lines. elife 10:10","journal-title":"elife"},{"issue":"14","key":"330_CR214","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1128\/JVI.00839-15","volume":"89","author":"L Steinbruck","year":"2015","unstructured":"Steinbruck L et al (2015) K1 and K15 of Kaposi's sarcoma-associated herpesvirus are partial functional homologues of latent membrane protein 2A of Epstein-Barr virus. J Virol 89(14):7248\u20137261","journal-title":"J Virol"},{"issue":"44","key":"330_CR215","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1073\/pnas.0402135101","volume":"101","author":"S Stewart","year":"2004","unstructured":"Stewart S et al (2004) Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. Proc Natl Acad Sci USA 101(44):15730\u201315735","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"330_CR216","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JVI.74.4.1727-1735.2000","volume":"74","author":"LJ Strobl","year":"2000","unstructured":"Strobl LJ et al (2000) Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol 74(4):1727\u20131735","journal-title":"J Virol"},{"issue":"18","key":"330_CR217","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1128\/JVI.01457-14","volume":"88","author":"MJ Strong","year":"2014","unstructured":"Strong MJ et al (2014) Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes. J Virol 88(18):10696\u201310704","journal-title":"J Virol"},{"key":"330_CR218","volume":"343","author":"Y Sun","year":"2024","unstructured":"Sun Y et al (2024) Regulation mechanism of EBV-encoded EBER1 and LMP2A on YAP1 and the impact of YAP1 on the EBV infection status in EBV-associated gastric carcinoma. Virus Res 343:199352","journal-title":"Virus Res"},{"issue":"14","key":"330_CR219","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1128\/JVI.78.14.7852-7860.2004","volume":"78","author":"N Sutkowski","year":"2004","unstructured":"Sutkowski N et al (2004) Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol 78(14):7852\u20137860","journal-title":"J Virol"},{"issue":"12","key":"330_CR220","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1128\/JVI.79.12.7355-7362.2005","volume":"79","author":"MA Swanson-Mungerson","year":"2005","unstructured":"Swanson-Mungerson MA et al (2005) Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J Virol 79(12):7355\u20137362","journal-title":"J Virol"},{"issue":"14","key":"330_CR221","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1128\/JVI.00433-06","volume":"80","author":"M Swanson-Mungerson","year":"2006","unstructured":"Swanson-Mungerson M, Bultema R, Longnecker R (2006) Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J Virol 80(14):6764\u20136770","journal-title":"J Virol"},{"issue":"Pt 9","key":"330_CR222","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1099\/vir.0.021444-0","volume":"91","author":"M Swanson-Mungerson","year":"2010","unstructured":"Swanson-Mungerson M, Bultema R, Longnecker R (2010) Epstein-Barr virus LMP2A imposes sensitivity to apoptosis. J Gen Virol 91(Pt 9):2197\u20132202","journal-title":"J Gen Virol"},{"issue":"2","key":"330_CR223","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/viro.1999.9964","volume":"263","author":"R Swart","year":"1999","unstructured":"Swart R, Fruehling S, Longnecker R (1999) Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction. Virology 263(2):485\u2013495","journal-title":"Virology"},{"issue":"22","key":"330_CR224","doi-asserted-by":"crossref","first-page":"10838","DOI":"10.1128\/JVI.74.22.10838-10845.2000","volume":"74","author":"R Swart","year":"2000","unstructured":"Swart R et al (2000) Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase\/Akt pathway. J Virol 74(22):10838\u201310845","journal-title":"J Virol"},{"issue":"2","key":"330_CR225","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1008171006400","volume":"19","author":"M Tanaka","year":"1999","unstructured":"Tanaka M et al (1999) Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan. Virus Genes 19(2):103\u2013111","journal-title":"Virus Genes"},{"issue":"4","key":"330_CR226","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V91.4.1373","volume":"91","author":"Q Tao","year":"1998","unstructured":"Tao Q et al (1998) Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91(4):1373\u20131381","journal-title":"Blood"},{"issue":"1","key":"330_CR227","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1(1):75\u201382","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"330_CR228","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/jvi.68.11.7374-7385.1994","volume":"68","author":"RJ Tierney","year":"1994","unstructured":"Tierney RJ et al (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68(11):7374\u20137385","journal-title":"J Virol"},{"issue":"2","key":"330_CR229","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11262-007-0118-8","volume":"35","author":"MJ Tomaszewski-Flick","year":"2007","unstructured":"Tomaszewski-Flick MJ, Rowe DT (2007) Minimal protein domain requirements for the intracellular localization and self-aggregation of Epstein-Barr virus latent membrane protein 2. Virus Genes 35(2):225\u2013234","journal-title":"Virus Genes"},{"issue":"10","key":"330_CR230","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41571-024-00930-x","volume":"21","author":"K Toner","year":"2024","unstructured":"Toner K, McCann CD, Bollard CM (2024) Applications of cell therapy in the treatment of virus-associated cancers. Nat Rev Clin Oncol 21(10):709\u2013724","journal-title":"Nat Rev Clin Oncol"},{"issue":"22","key":"330_CR231","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1128\/JVI.01699-12","volume":"86","author":"SI Tracy","year":"2012","unstructured":"Tracy SI et al (2012) Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol 86(22):12330\u201312340","journal-title":"J Virol"},{"issue":"6","key":"330_CR232","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2010-05-285791","volume":"117","author":"DT Vereide","year":"2011","unstructured":"Vereide DT, Sugden B (2011) Lymphomas differ in their dependence on Epstein-Barr virus. Blood 117(6):1977\u20131985","journal-title":"Blood"},{"issue":"4","key":"330_CR233","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/path.4198","volume":"230","author":"M Vockerodt","year":"2013","unstructured":"Vockerodt M et al (2013) Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle. J Pathol 230(4):399\u2013409","journal-title":"J Pathol"},{"issue":"4","key":"330_CR234","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002662","volume":"8","author":"AC Vrazo","year":"2012","unstructured":"Vrazo AC et al (2012) Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice. PLoS Pathog 8(4):e1002662","journal-title":"PLoS Pathog"},{"issue":"5","key":"330_CR235","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.177.5.2793","volume":"177","author":"H Wang","year":"2006","unstructured":"Wang H et al (2006) EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177(5):2793\u20132802","journal-title":"J Immunol"},{"issue":"1","key":"330_CR236","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3892\/etm.2016.3954","volume":"13","author":"F Wang","year":"2017","unstructured":"Wang F et al (2017) Lentivirus-mediated RNAi knockdown of LMP2A inhibits the growth of the Epstein-Barr-associated gastric carcinoma cell line GT38 in vitro. Exp Ther Med 13(1):187\u2013193","journal-title":"Exp Ther Med"},{"key":"330_CR237","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virol.2019.06.006","volume":"534","author":"J Wang","year":"2019","unstructured":"Wang J et al (2019) LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma. Virology 534:87\u201395","journal-title":"Virology"},{"issue":"25","key":"330_CR238","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.7150\/thno.44251","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang W et al (2020) CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC. Theranostics 10(25):11549\u201311561","journal-title":"Theranostics"},{"issue":"1","key":"330_CR239","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054010","volume":"8","author":"LR Wasil","year":"2013","unstructured":"Wasil LR et al (2013) The effect of Epstein-Barr virus latent membrane protein 2 expression on the kinetics of early B cell infection. PLoS One 8(1):e54010","journal-title":"PLoS One"},{"issue":"15","key":"330_CR240","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1128\/JVI.00958-15","volume":"89","author":"LR Wasil","year":"2015","unstructured":"Wasil LR et al (2015) Regulation of DNA damage signaling and cell death responses by Epstein-Barr virus latent membrane protein 1 (LMP1) and LMP2A in nasopharyngeal carcinoma cells. J Virol 89(15):7612\u20137624","journal-title":"J Virol"},{"issue":"22","key":"330_CR241","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1128\/MCB.20.22.8526-8535.2000","volume":"20","author":"G Winberg","year":"2000","unstructured":"Winberg G et al (2000) Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol Cell Biol 20(22):8526\u20138535","journal-title":"Mol Cell Biol"},{"issue":"48","key":"330_CR242","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1073\/pnas.1616574113","volume":"113","author":"T Wirtz","year":"2016","unstructured":"Wirtz T et al (2016) Mouse model for acute Epstein-Barr virus infection. Proc Natl Acad Sci USA 113(48):13821\u201313826","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"330_CR243","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s10637-013-0007-z","volume":"31","author":"CH Wong","year":"2013","unstructured":"Wong CH et al (2013) Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma. Investig New Drugs 31(6):1399\u20131408","journal-title":"Investig New Drugs"},{"issue":"1","key":"330_CR244","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","volume":"148","author":"Y Wong","year":"2022","unstructured":"Wong Y et al (2022) Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol 148(1):31\u201346","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"330_CR245","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1038\/s41467-018-07308-5","volume":"9","author":"T Xiang","year":"2018","unstructured":"Xiang T et al (2018) Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nat Commun 9(1):5009","journal-title":"Nat Commun"},{"key":"330_CR246","volume":"11","author":"TT Yang","year":"2021","unstructured":"Yang TT et al (2021) Zanubrutinib treatment of central nervous system posttransplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case report. Front Oncol 11:672052","journal-title":"Front Oncol"},{"issue":"5","key":"330_CR247","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3892\/ijo.2014.2342","volume":"44","author":"LF Yap","year":"2014","unstructured":"Yap LF et al (2014) Oncogenic effects of WNT5A in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Oncol 44(5):1774\u20131780","journal-title":"Int J Oncol"},{"issue":"3","key":"330_CR248","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/path.4460","volume":"235","author":"LF Yap","year":"2015","unstructured":"Yap LF et al (2015) Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma. J Pathol 235(3):456\u2013465","journal-title":"J Pathol"},{"issue":"7","key":"330_CR249","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1111\/cas.14435","volume":"111","author":"M Yasui","year":"2020","unstructured":"Yasui M et al (2020) Cancer stem cells in Epstein-Barr virus-associated gastric carcinoma. Cancer Sci 111(7):2598\u20132607","journal-title":"Cancer Sci"},{"issue":"10","key":"330_CR250","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1096\/fj.14-266718","volume":"29","author":"F Ye","year":"2015","unstructured":"Ye F et al (2015) Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China. FASEB J 29(10):4268\u20134272","journal-title":"FASEB J"},{"issue":"1","key":"330_CR251","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gene.2014.03.020","volume":"542","author":"X Ying","year":"2014","unstructured":"Ying X et al (2014) Lentivirus-mediated RNAi knockdown of LMP2A inhibits the growth of nasopharyngeal carcinoma cell line C666-1 in vitro. Gene 542(1):77\u201382","journal-title":"Gene"},{"issue":"8","key":"330_CR252","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41374-018-0034-7","volume":"98","author":"YL Yip","year":"2018","unstructured":"Yip YL et al (2018) Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. Lab Investig 98(8):1093\u20131104","journal-title":"Lab Investig"},{"issue":"1","key":"330_CR253","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imr.12792","volume":"291","author":"RM Young","year":"2019","unstructured":"Young RM et al (2019) Pathogenic B-cell receptor signaling in lymphoid malignancies: new insights to improve treatment. Immunol Rev 291(1):190\u2013213","journal-title":"Immunol Rev"},{"key":"330_CR254","volume":"322","author":"C Yu","year":"2022","unstructured":"Yu C et al (2022) Molecular mechanism of aquaporin 3 (AQP3) regulating by LMP2A and its crosstalk with 4E-BP1 via ERK signaling pathway in EBV-associated gastric cancer. Virus Res 322:198947","journal-title":"Virus Res"},{"issue":"1","key":"330_CR255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.18632\/oncotarget.2702","volume":"6","author":"YW Zhang","year":"2015","unstructured":"Zhang YW et al (2015) Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas. Oncotarget 6(1):207\u2013220","journal-title":"Oncotarget"},{"key":"330_CR256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2019.03.019","volume":"532","author":"Y Zhang","year":"2019","unstructured":"Zhang Y et al (2019) Constitutive activation of the canonical NF-kappaB signaling pathway in EBV-associated gastric carcinoma. Virology 532:1\u201310","journal-title":"Virology"},{"key":"330_CR257","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174688","volume":"915","author":"J Zhang","year":"2022","unstructured":"Zhang J et al (2022) Preclinical evaluation of the dual mTORC1\/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma. Eur J Pharmacol 915:174688","journal-title":"Eur J Pharmacol"},{"key":"330_CR258","doi-asserted-by":"crossref","first-page":"1331730","DOI":"10.3389\/fimmu.2023.1331730","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J et al (2023) LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells. Front Immunol 14:1331730","journal-title":"Front Immunol"},{"issue":"40","key":"330_CR259","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1073\/pnas.1607606113","volume":"113","author":"H Zheng","year":"2016","unstructured":"Zheng H et al (2016) Whole-exome sequencing identifies multiple loss-of-function mutations of NF-kappaB pathway regulators in nasopharyngeal carcinoma. Proc Natl Acad Sci USA 113(40):11283\u201311288","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"330_CR260","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/1878-0261.12824","volume":"14","author":"S Zheng","year":"2020","unstructured":"Zheng S et al (2020) Downregulation of adipose triglyceride lipase by EB viral-encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma. Mol Oncol 14(12):3234\u20133252","journal-title":"Mol Oncol"},{"issue":"1","key":"330_CR261","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s10020-022-00479-4","volume":"28","author":"Z Zhou","year":"2022","unstructured":"Zhou Z et al (2022) Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. Mol Med 28(1):55","journal-title":"Mol Med"},{"issue":"4","key":"330_CR262","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41419-020-2410-7","volume":"11","author":"J Zhu","year":"2020","unstructured":"Zhu J et al (2020) Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells. Cell Death Dis 11(4):213","journal-title":"Cell Death Dis"},{"issue":"8","key":"330_CR263","volume":"17","author":"N Zhu","year":"2021","unstructured":"Zhu N et al (2021) EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity. PLoS Pathog 17(8):e1009873","journal-title":"PLoS Pathog"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:09:50Z","timestamp":1759838990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":263,"URL":"https:\/\/doi.org\/10.1007\/82_2025_330","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"8 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}